CM
XBI icon

Caption Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Caption Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84.8M Buy
663,800
+445,000
+203% +$55.6M 0.5% 31
2025
Q4 		$26.7M Buy
+218,800
New +$25.1M 0.18% 123
2025
Q2 		– Sell
-125,000
Closed -$10.1M – 1966
2025
Q1 		$10.1M Buy
+125,000
New +$11.2M 0.1% 204
2024
Q4 		– Sell
-100,000
Closed -$9.88M – 1875
2024
Q3 		$9.88M Hold
100,000
– – 0.16% 155
2024
Q2 		$9.27M Sell
100,000
-100,000
-50% -$8.97M 0.14% 148
2024
Q1 		$19M Sell
200,000
-504,100
-72% -$46.8M 0.29% 74
2023
Q4 		$62.9M Buy
704,100
+620,000
+737% +$46M 0.85% 14
2023
Q3 		$6.14M Sell
84,100
-300,000
-78% -$24M 0.09% 266
2023
Q2 		$32M Buy
384,100
+240,000
+167% +$20.1M 0.57% 23
2023
Q1 		$11M Sell
144,100
-660,900
-82% -$54.8M 0.21% 111
2022
Q4 		$66.8M Sell
805,000
-130,000
-14% -$10.5M 1.04% 9
2022
Q3 		$74.2M Sell
935,000
-659,700
-41% -$55.6M 1.02% 8
2022
Q2 		$118M Buy
1,594,700
+1,104,600
+225% +$82.9M 1.63% 2
2022
Q1 		$44M Buy
490,100
+455,100
+1,300% +$42M 0.53% 23
2021
Q4 		$3.92M Buy
+35,000
New +$4.22M 0.04% 544
2021
Q2 		– Sell
-145,000
Closed -$19.7M – 1613
2021
Q1 		$19.7M Buy
+145,000
New +$21.7M 0.42% 38
2020
Q4 		– Sell
-100,000
Closed -$11.1M – 1286
2020
Q3 		$11.1M Hold
100,000
– – 0.26% 88
2020
Q2 		$11.2M Buy
+100,000
New +$9.85M 0.37% 47
2020
Q1 		– Sell
-50,000
Closed -$4.75M – 1115
2019
Q4 		$4.75M Buy
+50,000
New +$4.32M 0.16% 175
2019
Q2 		– Sell
-50,000
Closed -$4.53M – 847
2019
Q1 		$4.53M Buy
50,000
+10,000
+25% +$851K 0.25% 123
2018
Q4 		$2.87M Buy
+40,000
New +$3.22M 0.23% 134

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Caption Management's XBI Position: Q2 2025 in Review

Caption Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 97,473 shares — an estimated $7.78M sold.

Caption Management first reported a position in XBI in Q1 2020 and held it in 12 quarters. The position peaked at $15.1M in Q1 2022. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

  • Caption Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
  • Caption Management sold 97,473 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $7.78M.
  • Caption Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and held it in 12 quarters.
  • Caption Management's State Street SPDR S&P Biotech ETF position peaked at $15.1M in Q1 2022.
  • 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.